Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite Clinical Trial for ductal carcinoma-in-situ of the breast

Annals of Surgical Oncology

Volumn 13, Issue 7, 2006, Pages 967-976

  Jeruss, Jacqueline S ^a   Vicini, Frank A ^b   Beitsch, Peter D ^c   Haffty, Bruce G ^d   Quiet, Coral A ^e   Zannis, Victor J ^f   Keleher, Angela J ^g   Garcia, Delia M ^h   Snider, Howard C ⁱ   Gittleman, Mark A ^j   Whitacre, Eric ^k   Whitworth, Pat W ^l   Fine, Richard E ^m   Arrambide, Stacey ⁿ   Kuerer, Henry M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c Dallas Breast Center   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e Arizona Oncology Services   (United States)

^f Breast Care Center of the Southwest   (United States)

^g WESTERN PENNSYLVANIA HOSPITAL   (United States)

^h Orthopedic Center of St Louis   (United States)

ⁱ Alabama Breast Center Montgomery   (United States)

^j Sacred Heart Hospital   (United States)

^k Breast Center of Southern Arizona   (United States)

^l Nashville Breast Center   (United States)

^m Breast Center   (United States)

ⁿ Synergos Inc   (United States)

more..

Author keywords

Breast cancer; Cosmesis; MammoSite; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; BREAST ABSCESS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SIZE; CARCINOMA IN SITU; CELLULITIS; CLINICAL TRIAL; CONTRACTURE; DEVICE; ERYTHEMA; FEMALE; FOLLOW UP; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTITIS; MENOPAUSE; PATIENT SATISFACTION; RADIATION DERMATITIS; SEROMA; SKIN ATROPHY; SKIN DISCOLORATION; SKIN FIBROSIS; SKIN ULCER; STATISTICAL ANALYSIS; TELANGIECTASIA;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; INCIDENCE; MASTECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33745288784     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.08.031     Document Type: Article

References (27)

1. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16:441-52.
2. Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 2002; 52:256-76.
3. Kuerer HM, Julian TB, Strom EA, et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 2004; 239:338-51.
4. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004; 96:443-8.
5. Pawlik TM, Buchholz TA, Kuerer HM. The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg 2004; 199:479-92.
6. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachy-therapy applicator. Int J Radiat Oncol Biol Phys 2002; 52:1132-9.
7. Arthur DW, Vicini FA. MammoSite RTS: the reporting of initial experiences and how to interpret. Ann Surg Oncol 2004; 11:723-4.
8. Richards GM, Berson AM, Rescigno J, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 2004; 11:739-46.
9. Pawlik TM, Perry A, Strom EA, et al. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 2004; 100:490-8.
10. Zannis VJ, Walker LC, Barclay-White B, Quiet CA. Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter. Am J Surg 2003; 186:383-5.
11. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 55:289-93.
12. Vicini F, Baglan K, Kestin L, et al. The emerging role of brachytherapy in the management of patients with breast cancer. Semin Radiat Oncol 2002; 12:31-9.
13. Rose MA, Olivotto I, Cady B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg 1989; 124:153-7.
14. Image-detected breast cancer: state of the art diagnosis and treatment. International Breast Cancer Consensus Conference. J Am Coll Surg 2001; 193:297-302.
15. Mokbel K. Towards optimal management of ductal carcinoma in situ of the breast. Eur J Surg Oncol 2003; 29:191-7.
16. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999; 86:429-38.
17. Jensen RA, Page DL. Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions. Am J Surg Pathol 2003; 27:828-31.
18. Silverstein MJ. Not everyone with ductal carcinoma in situ of the breast treated with breast preservation needs post-excisional radiation therapy. Breast 2000; 9:189-93.
19. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003; 56:681-9.
20. Polgar C, Major T, Fodor J, et al. High-dose-rate brachy-therapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 2004; 60:1173-81.
21. Holland R, Hendriks JH, Vebeek AL, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335:519-22.
22. Holland R, Connolly JL, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 1990; 8:113-8.
23. Freedman GM, Anderson PR, Hanlon AL, et al. Pattern of local recurrence after conservative surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys 2005; 61:1328-36.
24. Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Williston Park) 2003; 17:1511-33; discussion 1533-4, 1539, 1542 passim.
25. Wood WC. The role of clinical trials in changing therapy for ductal carcinoma in situ. Ann Surg Oncol 2004; 11:24S-27S.
26. Cornfield DB, Palazzo JP, Schwartz GF, et al. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cancer 2004; 100:2317-27.
27. Recht A. Lessons of studies of breast-conserving therapy with and without whole-breast irradiation for patient selection for partial-breast irradiation. Semin Radiat Oncol 2005; 15:123-32.